Latest News

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Omeros Corporation announced today that the European Medicines Agency’s Committee for Orphan Medicinal Products issued a positive opinion recommending orphan drug designation of OMS721 for treatment in hematopoietic stem cell transplantation.

Source link

Related posts

Water Intoxication: How Much Water Is Fatal To The Body?


Canon’s New Alphenix 4D CT and C-Arm System for Interventional Procedures


Encapsulating biomedical micromotors in traditional pill form


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy